Detailed information for compound 935505

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 506.555 | Formula: C29H26N6O3
  • H donors: 4 H acceptors: 5 LogP: 5.11 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 2
  • SMILES: COc1cc2c(Nc3ccc(cc3)NC(=O)c3ccccc3)nc(nc2cc1O)NCCc1ccccn1
  • InChi: 1S/C29H26N6O3/c1-38-26-17-23-24(18-25(26)36)34-29(31-16-14-20-9-5-6-15-30-20)35-27(23)32-21-10-12-22(13-11-21)33-28(37)19-7-3-2-4-8-19/h2-13,15,17-18,36H,14,16H2,1H3,(H,33,37)(H2,31,32,34,35)
  • InChiKey: LCHQFTFHRSXLRC-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Escherichia coli fused N-acetyl glucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyl transferase Starlite/ChEMBL References
Homo sapiens interleukin-1 receptor-associated kinase 4 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Mycobacterium ulcerans bifunctional N-acetylglucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyltransferase Get druggable targets OG5_131193 All targets in OG5_131193
Mycobacterium leprae Probable UDP-N-acetylglucosamine pyrophosphorylase GlmU Get druggable targets OG5_131193 All targets in OG5_131193
Mycobacterium tuberculosis Probable UDP-N-acetylglucosamine pyrophosphorylase GlmU Get druggable targets OG5_131193 All targets in OG5_131193
Wolbachia endosymbiont of Brugia malayi N-acetylglucosamine-1-phosphate uridyltransferase Get druggable targets OG5_131193 All targets in OG5_131193

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Toxoplasma gondii fructose-bisphospatase II 0.1378 1 1
Mycobacterium ulcerans bifunctional N-acetylglucosamine-1-phosphate uridyltransferase/glucosamine-1-phosphate acetyltransferase 0.0684 0.1987 0.5
Wolbachia endosymbiont of Brugia malayi N-acetylglucosamine-1-phosphate uridyltransferase 0.0684 0.1987 0.5
Mycobacterium tuberculosis Probable UDP-N-acetylglucosamine pyrophosphorylase GlmU 0.0684 0.1987 0.5
Trypanosoma cruzi fructose-1,6-bisphosphatase, cytosolic, putative 0.1378 1 1
Leishmania major 0.1378 1 0.5
Echinococcus multilocularis fructose 1,6 bisphosphatase 1 0.1378 1 0.5
Trypanosoma brucei fructose-1,6-bisphosphatase 0.1378 1 1
Loa Loa (eye worm) fructose-1,6-bisphosphatase 0.1378 1 0.5
Schistosoma mansoni fructose-16-bisphosphatase-related 0.1378 1 0.5
Echinococcus granulosus fructose 16 bisphosphatase 1 0.1378 1 0.5
Mycobacterium leprae Probable UDP-N-acetylglucosamine pyrophosphorylase GlmU 0.0684 0.1987 0.5
Trypanosoma cruzi fructose-1,6-bisphosphatase, cytosolic, putative 0.1378 1 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.579 uM Inhibition of human IRAK4 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) = 0.65 uM Inhibition of Escherichia coli ATCC 27325 GlmU expressed in Escherichia coli HMS174(DE3) incubated for 15 mins prior to MgCl2 addition measured after 30 mins by malachite green staining-based assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human AURKB incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human IRAK1 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human JAK1 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human JAK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human JAK3 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human CDK1 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human CDK2 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
IC50 (binding) > 30 uM Inhibition of human CDK9 incubated for 20 mins prior to MgCl2 addition measured after 90 mins by mobility shift assay ChEMBL. 25262942
PB (ADMET) > 99 % Serum protein binding in human at 10 uM after 30 mins by ultrafiltration method ChEMBL. 25262942

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.